OCS
NASDAQ · Pharmaceuticals
Oculis Holding Ag
$12.98
+0.60 (+4.85%)
Open$12.75
Previous Close$12.38
Day High$13.01
Day Low$12.41
52W High$34.48
52W Low$10.52
Volume—
Avg Volume351.7K
Market Cap707.76M
P/E Ratio—
EPS$-1.72
SectorPharmaceuticals
Analyst Ratings
Strong Buy
16 analysts
Price Target
+110.4% upside
Current
$12.98
$12.98
Target
$27.31
$27.31
$14.95
$27.31 avg
$37.18
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 335.81M | 321.14M | 281.93M |
| Net Income | 75.81M | 72.36M | 63.56M |
| Profit Margin | 22.6% | 22.5% | 22.5% |
| EBITDA | 137.16M | 117.64M | 104.92M |
| Free Cash Flow | 80.35M | 48.21M | 59.98M |
| Rev Growth | +1.2% | -6.4% | +18.4% |
| Debt/Equity | 0.56 | 0.65 | 0.60 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,185.71 | -0.52% | 41.4 | 1.11T |
| JNJ | Johnson & Johnson | $259.24 | +0.88% | 29.3 | 617.08B |
| MRK | Merck & Co. Inc. | $128.58 | +0.16% | 99.4 | 315.27B |
| PFE | Pfizer Inc. | $26.76 | +2.14% | 34.8 | 150.87B |
| BMY | Bristol-Myers Squibb Co | $64.72 | +0.89% | 14.1 | 131.10B |
| ZTS | Zoetis Inc | $72.66 | -5.97% | 12.3 | 32.39B |